Figure 5From: Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy Barasertib-HQPA ability to modulate cellular motility. Wound healing assay was performed at 24-48 h with 30 and 300 nM barasertib-HQPA. Cell migration was quantified with ImageJ® analysis software and results are expressed as percentage of average gab vs drug concentration. *p < 0.05 vs untreated cells.Back to article page